Swiss Cancer Institute

This large, late-stage trial is testing if a drug that helps prevent painful bone complications in people with metastatic breast or prostate cancer is just as effective when given every 12 weeks instead of the standard every 4 weeks. The goal is to see if the less frequent schedu…

This trial is testing whether lower doses of chemotherapy and radiation can effectively treat a type of testicular cancer called seminoma. The goal is to control the cancer while reducing the risk of serious long-term side effects from standard, more intense treatments. It is for…

This trial is testing a more personalized approach to treating an aggressive blood cancer called diffuse large B-cell lymphoma (DLBCL). It aims to see if adjusting the standard treatment based on early results from PET scans and a special blood test (ctDNA) can improve outcomes. …

This trial is testing if adding chest radiation therapy to a maintenance immunotherapy drug (durvalumab) can better control advanced small cell lung cancer. Patients first receive standard chemotherapy combined with durvalumab. If the cancer responds or stays stable, they then re…

This study is testing a new treatment approach for muscle-invasive bladder cancer. It combines a liquid treatment placed directly into the bladder (BCG) with standard chemotherapy and an immunotherapy drug given by IV. The main goal is to see if this combination can completely cl…